Context Routine symptom assessment represents the cornerstone of symptom management.
Edmonton Symptom Assessment System (ESAS) is one of the first quantitative symptom …

Good symptom management in oncology is associated with improved patient and family
quality of life, greater treatment compliance, and may even offer survival advantages. With …

PurposeTreatment with programmed cell death-1 or programmed death ligand 1 (PD-(L) 1)
inhibitors is now standard therapy for patients with lung cancer. The immunosuppressive …

Fatigue is the most common symptom experienced by patients during the cancer trajectory
from diagnosis to the end of life and is defined as a distressing, persistent, subjective sense …

Cervical cancer is one of the gravest threats to women's lives. It is estimated that over a
million women worldwide currently have cervical cancer. Most of these women have not …

Cancer-related fatigue is defined as a distressing, persistent, subjective sense of physical,
emotional, and/or cognitive tiredness or exhaustion related to cancer or cancer treatment …

Fatigue is one of the most common adverse effects of cancer that might persist for years after
treatment completion in otherwise healthy survivors. Cancer-related fatigue causes …

PURPOSE Baseline use of corticosteroids is associated with poor outcomes in patients with
non–small-cell lung cancer (NSCLC) treated with programmed cell death-1 axis inhibition …

PURPOSE To provide guidance on the clinical management of dyspnea in adult patients
with advanced cancer. METHODS ASCO convened an Expert Panel to review the evidence …

Pancreatic cancer is one of our most lethal malignancies. Despite substantial improvements
in the survival rates for other major cancer forms, pancreatic cancer survival rates have …